BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 20053780)

  • 1. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
    Marcu JP; Christian RT; Lau D; Zielinski AJ; Horowitz MP; Lee J; Pakdel A; Allison J; Limbad C; Moore DH; Yount GL; Desprez PY; McAllister SD
    Mol Cancer Ther; 2010 Jan; 9(1):180-9. PubMed ID: 20053780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells.
    Arnold JC; Hone P; Holland ML; Allen JD
    Pharmacol Rep; 2012; 64(3):751-7. PubMed ID: 22814029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83.
    Cerretani D; Collodel G; Brizzi A; Fiaschi AI; Menchiari A; Moretti E; Moltoni L; Micheli L
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model.
    Scott KA; Dalgleish AG; Liu WM
    Mol Cancer Ther; 2014 Dec; 13(12):2955-67. PubMed ID: 25398831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.
    McMahon LR
    Drug Alcohol Depend; 2016 Aug; 165():87-93. PubMed ID: 27289270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
    Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis.
    Becker W; Alrafas HR; Busbee PB; Walla MD; Wilson K; Miranda K; Cai G; Putluri V; Putluri N; Nagarkatti M; Nagarkatti PS
    J Crohns Colitis; 2021 Jun; 15(6):1032-1048. PubMed ID: 33331878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
    De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V
    Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
    Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
    J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Δ-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: involvement of cannabinoid receptor 2 and p38 MAPK.
    Yamaori S; Ishii H; Chiba K; Yamamoto I; Watanabe K
    Toxicology; 2013 Dec; 314(2-3):254-61. PubMed ID: 24184660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
    Booker L; Naidu PS; Razdan RK; Mahadevan A; Lichtman AH
    Drug Alcohol Depend; 2009 Nov; 105(1-2):42-7. PubMed ID: 19679411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
    Greenhough A; Patsos HA; Williams AC; Paraskeva C
    Int J Cancer; 2007 Nov; 121(10):2172-80. PubMed ID: 17583570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.